Limited Systemic Sclerosis - 3 Studies Found
Completed |
: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma :
: 2013-06-05 |
Completed |
: Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet : Ischemia : 2010-02-19 : Drug: ambrisentan Subjects will receive ambrisentan 5 mg orally once daily or identical placebo pills fo |
Withdrawn |
: Systemic Sclerosis Clinical and Biomarker Study :
: 2015-08-20 |